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Abstract
Objectives To develop and validate a delirium prediction model for adult
intensive care patients and determine its additional value compared with
prediction by caregivers.
Design Observational multicentre study.
Setting Five intensive care units in the Netherlands (two university
hospitals and three university affiliated teaching hospitals).
Participants 3056 intensive care patients aged 18 years or over.
Main outcome measure Development of delirium (defined as at least
one positive delirium screening) during patients’ stay in intensive care.
Results The model was developed using 1613 consecutive intensive
care patients in one hospital and temporally validated using 549 patients
from the same hospital. For external validation, data were collected from
894 patients in four other hospitals. The prediction (PRE-DELIRIC) model
contains 10 risk factors—age, APACHE-II score, admission group, coma,
infection, metabolic acidosis, use of sedatives and morphine, urea
concentration, and urgent admission. The model had an area under the
receiver operating characteristics curve of 0.87 (95% confidence interval
0.85 to 0.89) and 0.86 after bootstrapping. Temporal validation and
external validation resulted in areas under the curve of 0.89 (0.86 to
0.92) and 0.84 (0.82 to 0.87). The pooled area under the receiver
operating characteristics curve (n=3056) was 0.85 (0.84 to 0.87). The
area under the curve for nurses’ and physicians’ predictions (n=124)
was significantly lower at 0.59 (0.49 to 0.70) for both.
Conclusion The PRE-DELIRICmodel for intensive care patients consists
of 10 risk factors that are readily available within 24 hours after intensive
care admission and has a high predictive value. Clinical prediction by
nurses and physicians performed significantly worse. The model allows
for early prediction of delirium and initiation of preventive measures.
Trial registrationClinical trials NCT00604773 (development study) and
NCT00961389 (validation study).
Introduction
Delirium, characterised by an acute onset of fluctuating changes
in mental status and changed levels of consciousness and
inattentiveness,1 has a high incidence rate in critically ill
patients.2-4 It is a serious disorder associated with prolonged
stays in intensive care units and hospitals, higher costs, and
increased morbidity and mortality.2 3 5
Several tools are available for assessing delirium in intensive
care patients, of which the confusion assessment
method—intensive care unit (CAM-ICU) has the highest
sensitivity and specificity.6 7 Screening intensive care patients
is important,8-10 so that timely treatment can be provided.
However, preventive measures for deliriummay also reduce its
incidence, severity, and duration, as determined in other groups
of patients.11 12General preventive measures in all intensive care
patients are time consuming and may expose a substantial
number of patients to unnecessary risks such as the adverse
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effects of drug prophylaxis. Although several predictive models
for non-intensive care patients exist,13 14 as well as one for older
medical intensive care patients,15 no evidence based prediction
model for general intensive care patients is available. The aim
of our study was to develop and validate a delirium prediction
model for intensive care patients and to determine its value
compared with prediction by the attending nurses and
physicians.
Methods
Study design
This was an observational multicentre study in which we firstly
developed the PREdiction of DELIRium for Intensive Care
patients (PRE-DELIRIC) model and then temporally validated
it in a second prospective cohort in the same hospital. We then
validated the model externally in four other Dutch hospitals.
Development and temporal validation of the
model
To develop the prediction model, we did a prospective cohort
study in the Radboud University Nijmegen Medical Centre in
the Netherlands. This study took place between 1 February 2008
and 1 February 2009.We did a second prospective cohort study
in the same hospital for temporal validation of the model
between 1 May and 1 September 2009.16
External validation
After development and temporal validation, we externally
validated the delirium prediction model with data from intensive
care patients admitted to four other Dutch hospitals between 1
January and 1 September 2009. One of these hospitals was a
university hospital, and three were university affiliated teaching
hospitals; all had mixed intensive care populations (table 1⇓).
In these hospitals, trained intensive care nurses used the
CAM-ICU at least twice daily.
Delirium prediction by caregivers
To compare the predictive value of the model with that of the
caregivers, we asked intensive care nurses and physicians caring
for the patient to predict independently, within 24 hours after
admission to intensive care, if patients would develop a delirious
period during their complete stay in intensive care.
Study population for development and
validation studies
After the successful implementation of the validated Dutch
version of the CAM-ICU,17 the inter-rater reliability of the
delirium screenings by the intensive care nurses was above 0.80
Cohen’s κ, with a compliance rate of more than 90%, as
described in more detail previously.10 During the development
and temporal validation studies, we included all adult patients
admitted to the intensive care unit. To detect delirium, intensive
care nurses screened all consecutive adult intensive care patients
at least three times daily, and more often if required (for
example, after sudden changes in behaviour, attention, or
consciousness). This frequency of screening was in accordance
with screening in daily practice. We excluded patients if they
were delirious within 24 hours after admission to intensive care,
had a sustained Richmond agitation sedation score (RASS) of
−4/−5 during the complete intensive care admission, stayed on
the intensive care unit for less than one day, had serious auditory
or visual disorders, were unable to understand Dutch, were
severely mentally disabled, or had a serious receptive aphasia
or if the compliance rate of the delirium screening was less than
80% during a patient’s stay in the intensive care unit.
To meet the same inclusion and exclusion criteria during the
external validation study, we used consecutive patients with
complete CAM-ICU screenings, defined as a CAM-ICU
compliance rate above 80% per patient. We defined patients as
having delirium when they had at least one positive CAM-ICU
screening during their intensive care stay or were treated with
haloperidol, as in these hospitals haloperidol is used only for
treatment of delirium. To examine the predictive value of the
PRE-DELIRIC model in daily practice in these hospitals, we
did no compliance and inter-rater reliability measurements and
used only data from CAM-ICU screenings as done in normal
daily practice.
Potential predictors
We collected demographic variables and information on
potential risk factors identified by a recent systematic review.18
We collected these data electronically within 24 hours of
admission to intensive care (web appendix A). In addition, we
included variables from the Dutch national intensive care
evaluation database as potential risk factors when the delirium
incidence rate associated with that variable was more than 50%
higher than the incidence rate of the total group (web appendix
B).19 Wherever possible, the risk factors were collected as
continuous variables (categorical or dichotomised when
otherwise).
Outcome definition
In view of our aim to develop and validate a delirium prediction
model, the main outcomemeasure was development of delirium
during patients’ stay in the intensive care unit. We defined
delirium as a minimum of one positive CAM-ICU screening
during each patient’s intensive care stay. In addition, we
screened patients’ medical and nursing files daily for signs of
delirium.20 If the files provided signs of delirium without a
positive CAM-ICU screening or, conversely, if the files did not
provide evidence of delirium and the patient had a positive
CAM-ICU result, a delirium expert additionally screened
patients according to the Diagnostic and Statistical Manual of
Mental Disorders, fourth edition (DSM-IV) criteria to rule out
false negatives and false positives.1
Data management and quality checks for
development and temporal validation studies
Wemonitored the performance of CAM-ICU screening to ensure
the quality of data collection. We calculated compliance as the
percentage of assessments done each day in relation to the total
number of assessments that should have been done. The mean
compliance during the development and temporal validation
studies was 90.4%. We measured the quality of CAM-ICU
performance as the inter-rater reliability. For this, we compared
the CAM-ICU screening assessed by the attending intensive
care nurse with the CAM-ICU score assessed by an expert
psychiatry nurse within a time window of one hour.We did 120
inter-rater reliability measurements, resulting in a Cohen’s κ of
0.90 (95% confidence interval 0.82 to 0.98). The first author
randomly double checked data from 15% of all patients included
for completeness and accuracy.
Statistical analysis
We calculated the sample size needed for the development of
the model on the basis of the need for 10-15 delirious patients
per risk factor plus 10% dropout. We imputed missing data for
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the risk factors. Values were missing in the development study
for urea (0.7%), liver enzymes (3.0%), bilirubin (18.0%),
calcium (4.5%), sodium (0.3%), haematocrit (0.4%), metabolic
acidosis (1.0%), and acute physiology and chronic health
evaluation (APACHE)-II scores (0.7%). Data for all other
variables were complete. All data for the temporal validation
study were complete. We decided that if a laboratory
measurement was not determined we had no reason to assume
that the missing variable had an abnormal value, and we imputed
the mean normal value. To calculate the normal value, we
selected all patients with a normal value and then calculated the
mean value for this group of patients and used it for imputation.
When the APACHE-II score was missing, we imputed the mean
value for the delirium or non-delirium group, depending on the
results of the CAM-ICU. In the external validation dataset, 6.3%
of the urea values were missing and imputed. For APACHE-II,
0.6% of the scores were missing, and we imputed a mean
APACHE-II score for the group in the external validation set.
We used univariate logistic regression to develop the prediction
model by assessing the association between each potential
prognostic determinant and the presence or absence of delirium.
We excluded determinants with a P value above 0.15 in
univariate analysis or with a prevalence rate below 10%. With
the remaining risk factors, we used multivariate logistic
regression analysis with backward elimination (excluding risk
factors with P values over 0.10) to evaluate the independent
associations with the occurrence of delirium. The final model
therefore contains independent risk factors for delirium. We
estimated the prognostic ability of the model to discriminate
between patients with and without delirium by using the area
under the receiver operating characteristics curve (AUROC).
We used bootstrapping techniques to adjust for overfitting—that
is, for overly optimistic estimates of the regression coefficients
of the risk factors in the final model. Two hundred random
bootstrap samples resulted in shrunken regression coefficients
of the risk factors and area under the curve of the developed
model.21
In both validation studies, we multiplied shrunken regression
coefficients for each risk factor by the observed patients’ values.
The outcome is a calculated predicted probability on which we
built a new AUROC. Finally, to examine how well the model
was calibrated, we calculated linear predictor values for each
patient of every cohort by using the coefficients from the final
development model.We used these linear predictors in a logistic
regression model to test whether the prediction rule was well
calibrated, resulting in a calibration slope and an intercept. A
calibration slope of 1 and an intercept of 0 show a perfect
calibration. Calibration plots for each cohort are available in
web appendix D. We used SPSS 16.01, R statistics version
2.10.1,22 using the rms package,23 for all analyses.
Results
Development of prediction model
In total, we screened 2116 consecutive patients and excluded
503 of them (fig 1⇓). Of the remaining 1613 patients, 411
(25.5%) developed delirium. Table 2⇓ shows patients’
characteristics, and web appendices B and C contain prevalence
rates and delirium incidence rates for the separate risk factors.
Of the 25 potential risk factors, we excluded alcohol misuse
(7.8%), dementia (1.7%), use of an epidural catheter (2.2%),
hyperamylasaemia (3.9%), hyponatraemia (5.8%), use of
dopamine (0.2%), and use of lorazepam (0.7%) because of a
prevalence rate below 10%.We excluded hypertension because
of a P value above 0.15 in univariate logistic regression analysis.
After multivariate logistic regression analysis with the remaining
risk factors, we constructed the PRE-DELIRIC model, which
consisted of 10 risk factors (table 3⇓). The AUROC was 0.87
(95% confidence interval 0.85 to 0.89) and 0.86 after
bootstrapping. Calibration of the model resulted in a calibration
slope of 1.08 and an intercept of −0.06. The box shows the
formula for the PRE-DELIRIC model.
Temporal validation of prediction model
In the prospective validation study, we screened 748 consecutive
patients and excluded 199 of them (fig 1⇓). Of the remaining
549 patients, 171 (31.1%) developed delirium (table 2⇓). The
temporal validation resulted in an AUROC of 0.89 (0.86 to
0.92). The calibration slope of the temporal model was 1.2, and
the intercept was 0.22.
External validation of prediction model
We used data from 894 non-selected intensive care patients
(table 2⇓) for external validation, resulting in an AUROC of
0.84 (0.82 to 0.87) with a calibration slope of 0.76 and an
intercept of −0.59. The AUROCs of the four different hospitals
did not differ from each other (data not shown). As no
differences in prediction existed between the three studies, we
pooled the data (n=3056), resulting in an AUROC of 0.85 (0.84
to 0.87) (fig 2⇓). The pooled data resulted in an overall
calibration slope of 0.93 with an intercept of −0.29, indicating
good calibration.
We divided the complete group into four different risk groups;
low, moderate, high, and very high risk, with PRE-DELIRIC
scores of 0-20%, >20-40%, >40-60%, and >60%. Figure 2⇓
shows the sensitivity, specificity, and likelihood ratios for each
risk group. Figure 3⇓ shows the calibration plot of the pooled
data.
Delirium prediction by caregivers
In a convenience sample of 124 patients, we asked attending
intensive care nurses and physicians to predict delirium,
independently of each other, within 24 hours of patients’
admission to intensive care. The AUROC for prediction by the
nurses (0.59, 0.49 to 0.70) and physicians (0.59, 0.49 to 0.70)
was inferior to the predictive value of the PRE-DELIRICmodel
(0.87, 0.81 to 0.93) in this specific subgroup of 124 patients.
We found no significant differences between the prediction
made by intensive care nurses (75% of sample) and student
intensive care nurses (25%) or between predictions made by
intensivists (36%), fellow-intensivists (40%), or residents (24%)
(data not shown).
Discussion
In this multicentre study, we developed and validated a model
for predicting delirium in intensive care patients. To our
knowledge, this is the first delirium prediction study for general
intensive care patients and represents by far the largest delirium
related study in intensive care patients to date. Our
PRE-DELIRIC model reliably predicted the development of
delirium for the complete length of stay in intensive care, on
the basis of 10 readily available risk factors within 24 hours of
admission to intensive care. In addition, the area under the
receiver operating characteristics curve of the PRE-DELIRIC
model was significantly higher than the delirium prediction
capacity of attending caregivers. These findings confirm that
the model has additional value in daily practice. Importantly,
dementia and alcohol misuse are not included the model, as
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Formula for PRE-DELIRIC model
Risk of delirium = 1/(1+exp−(−6.31
+ 0.04 × age
+ 0.06 × APACHE-II score
+ 0 for non-coma or 0.55 for drug induced coma or 2.70 for miscellaneous coma or 2.84 for combination coma
+ 0 for surgical patients or 0.31 for medical patients or 1.13 for trauma patients or 1.38 for neurology/neurosurgical patients
+ 1.05 for infection
+ 0.29 for metabolic acidosis
+ 0 for no morphine use or 0.41 for 0.01-7.1 mg/24 h morphine use or 0.13 for 7.2-18.6 mg/24 h morphine use or 0.51 for >18.6 mg/24
h morphine use
+ 1.39 for use of sedatives
+ 0.03 × urea concentration (mmol/L)
+ 0.40 for urgent admission))
The scoring system’s intercept is expressed as −6.31; the other numbers represent the shrunken regression coefficients
(weight) of each risk factor.
these patients need to be considered as high risk patients
irrespective of the presence of other risk factors.
Clinical relevance
The early prediction of development of delirium in intensive
care patients with the PRE-DELIRIC model facilitates the use
of non-drug preventive measures in high risk patients, such as
improvement of orientation, cognitive stimulation, early
mobilisation,11 and listening to music.24 It also facilitates drug
interventions in high risk patients, such as the administration
of prophylactic haloperidol.12These interventions aim to improve
patients’ cognition or have a systemic effect, although the
evidence of beneficial preventive measures with drugs and
nursing interventions in critically ill patients is limited at this
moment.25 Non-drug preventive measures were successful in
reducing the incidence and duration of delirium in a
non-critically ill hospital population with an intermediate to
high risk for the development of delirium,11 and prevention with
haloperidol resulted in reduced severity of delirium and fewer
days with delirium, as well as a shorter length of stay in
hospital.12 Importantly, no data from intensive care patients are
available. Interestingly, early mobilisation of mechanically
ventilated patients in intensive care, besides other significant
effects, resulted in a reduced duration of delirium.26
The use of the PRE-DELIRIC model to identify and
consequently preventively treat high risk patients could offer
an important contribution to intensive care practice and ensure
efficient use of research resources to study only high risk
patients. In addition, the modifiable risk factors of the model
may facilitate the use of preventive measures. Currently, the
PRE-DELIRIC model is used in clinical daily practice in the
hospital that developed the model; intensive care patients with
a high risk of delirium (≥50% PRE-DELIRIC score), and
patients with dementia or alcohol misuse, receive preventive
measures. The optimal cut-off point of the PRE-DELIRICmodel
and the most effective delirium preventive interventions for
intensive care patients need to be studied in the near future.
Limitations of study
Our study had several limitations. Firstly, although the
CAM-ICU has a high sensitivity and specificity when used by
dedicated research nurses,27 28 its performance in daily practice
as used by bedside nurses recently proved to be lower.29 In this
performance study, the CAM-ICU was measured at one point
on one day, whereas our diagnosis of delirium was based on all
CAM-ICU screenings during patients’ complete stay in intensive
care, increasing the sensitivity of the test. We also used
haloperidol as a proxy for the diagnosis of delirium, as in all
participating centres haloperidol was used only to treat delirium,
and the hospitals with the highest CAM-ICU performance
participated in this delirium prediction study. In view of the
fluctuating nature of delirium, all patients were screened three
times daily and more often if needed. When delirium was not
detected with the CAM-ICU but suspected on the basis of
medical and nursing reports, patients were additionally screened
by a delirium expert according to the DSM-IV criteria.1 In
addition, during the development and temporal validation study,
we did quality checks that showed a high compliance rate and
inter-rater reliability. We therefore presume that few patients
were misdiagnosed.
Secondly, we used data collected from four other hospitals in
the same study period. These centres implemented and clinically
used the CAM-ICU combinedwith a delirium treatment protocol
before the conduct of the study. For the external validation
study, we included only patients with complete CAM-ICU
screenings and those who were treated with haloperidol for
delirium. The case mix of these patients showed a higher
APACHE-II score and more sedated patients, and more patients
were admitted for medical reasons compared with the hospital
where the primary development and validation studies were
done. These differences may explain the higher incidence of
delirium in these hospitals. Because of logistic reasons and the
fact that we wanted to examine the predictive value of the
PRE-DELIRIC model in daily intensive care practice, we did
not do quality checks such as inter-rater reliability measurements
in these other hospitals. Despite these limitations, the
PRE-DELIRIC model showed a good predictive value in daily
intensive care practice.
Thirdly, as recommended,21 the risk factors used in our study
were primarily based on a systematic review.18 We included
additional variables following the results of our first cohort. We
added “diagnosis group” and “urgent admission” as new risk
factors because of a high incidence of delirium associated with
these items. Although these variables were not found in the
systematic review,18 some studies show that urgent admission
to intensive care and neurological conditions are risk factors for
delirium.30 31 The results of our development study show that
these risk factors are of importance in predicting delirium in
intensive care patients. Because of a low prevalence rate,
relevant risk factors such as hyponatraemia, alcohol misuse,
and dementia were excluded from the multivariate logistic
regression analysis. The additional value of hyponatraemia for
the model would be expected to be low, as the incidence of
delirium in patients with hyponatraemia in the first 24 hours
after admission to intensive care is low. The importance of, for
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example, dementia and alcohol misuse is recognised in several
studies,4 32 and the incidence of delirium in these patients was
also high in our study. In many institutes, all these patients will
receive preventive measures so physicians do not need a
delirium prediction model in these particular subgroups.
Moreover, adding these covariates to the model would decrease
its sensitivity to the other covariates. For these reasons, we did
not include alcohol misuse and dementia in the PRE-DELIRIC
model.
Fourthly, the negative likelihood ratio for patients with a
predicted low chance of developing delirium is relatively rather
moderate. This indicates that, in this group, patients will develop
delirium while they are classified as having a low risk. On the
other hand, preventive measures are advised in patients with a
high risk, and the higher the risk of delirium the better the
performance of the model. Nevertheless, a predicted low risk
does not exclude the possibility of development of delirium.
Finally, the PRE-DELIRIC model is a static model that yields
a calculated probability for delirium 24 hours after admission
to intensive care. As the health status of patients can improve
or deteriorate during their stay in intensive care, the probability
of development of delirium may also change. Our model does
not take into account changes in health status. Despite this
limitation of the PRE-DELIRIC model, the area under the
receiver operating characteristics curve of the model is high.
Even so, development of a dynamic prediction model using
dynamic parameters, such as the sequential organ failure
assessment (SOFA) score would be interesting, to improve its
predictive value during the patients’ stay on the intensive care
unit, which may also result in a better performance in the low
risk group.
Conclusions and policy implications
The PRE-DELIRICmodel can predict delirium for the complete
stay in the intensive care within 24 hours of admission. We can
now identify patients who have a high risk of developing
delirium during their intensive care stay. This will facilitate
targeted initiation of preventive measures. Our study shows that
the use of the PRE-DELIRIC model is significantly better than
the predictions of the attending caregivers, and it should
therefore be used daily in intensive care practice.
An automatic version of the PRE-DELIRIC model (Excel and
web based) can be downloaded at www.umcn.nl/Research/
Departments/intensive%20care/Pages/vandenBoogaard.aspx
(English and Dutch version available).
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What is already known on this topic
Delirium is a common and serious disorder related to morbidity and mortality
Several risk factors for delirium in intensive care patients are recognised, but no delirium prediction model is available
What this study adds
A delirium prediction model has been developed and validated
The PRE-DELIRIC model enables the physician to predict delirium within 24 hours after admission to intensive care for the complete
stay in intensive care
This model may facilitate early identification of high risk patients and targeted early initiation of preventive measures
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care unit: occurrence and clinical course in older patients. J AmGeriatr Soc 2003;51:591-8.
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Tables
Table 1| Characteristics of participating hospitals
CAM-ICU screeningCAM-ICU implementationICU population
ICU beds for adults
(annual admissions)Participating hospitals
3/day; compliance rate 90%;
IRR>0.8
2007; group and individual
training
Medicine, surgery, neurocritical
care, and cardiothoracic surgery
33 beds (2000-2500)Radboud University Nijmegen
Medical Centre, Nijmegen*
2/day; compliance and IRR not
measured
2007; group and individual
training
Medicine, surgery, neurocritical
care, and cardiothoracic surgery
32 beds (2000-2500)University Medical Centre
Utrecht, Utrecht*
3/day; compliance rate 90%; IRR
not measured
2008; group and individual
training
Medicine, surgery, and
cardiothoracic surgery
16 beds (1400-1500)Medical Centre Leeuwarden,
Leeuwarden†
3/day; compliance rate 90%; IRR
not measured
2004; group and individual
training
Medicine and surgery10 beds (600)Gelre Hospital, Apeldoorn†
3/day; compliance rate 96%; IRR
not measured
2006; group and individual
training
Medicine, surgery, and
cardiothoracic surgery
18 beds (1500-1800)Onze Lieve Vrouwe Gasthuis,
Amsterdam†
CAM=confusion assessment method; ICU=intensive care unit; IRR=inter-rater reliability expressed as Cohen’s κ.
*University hospital.
†University affiliated teaching hospital.
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Table 2| Patients’ characteristics in cohort studies. Values are numbers (percentages) unless stated otherwise
All included patients (n=3056)
External validation study
(n=894)
Temporal validation study
(n=549)
Development study
(n=1613)Variable
65 (55-73, 78)67 (58-75, 78)64 (54-73, 72)64 (54-72, 76)Median (IQR, range) age (years)
1937 (63.4)557 (62.3)353 (64.3)1027 (63.7)Male sex
15 (12-19, 48)16 (13-21, 44)15 (11-18, 47)14 (11-18, 41)Median (IQR, range) APACHE-II score
911 (29.8)329 (36.8)171 (31.1)411 (25.5)Delirium
NANA2 (2-5, 44)2 (2-5, 53)Median (IQR, range) days to onset of
delirium
1579 (51.7)495 (55.4)232 (42.3)852 (52.8)Urgent admission
2545 (83.3)801 (89.6)478 (87.1)1266 (78.5)Mechanical ventilation
1113 (36.4)543 (60.7)184 (33.5)386 (23.9)Sedation
3 (2-7, 118)4 (2-8, 100)2 (2-4, 69)2 (2-4, 118)Median (IQR, range) length of stay in ICU
(days)
10 (5-19, 249)10 (6-20, 88)9 (5-15, 98)9 (5-19, 247)Median (IQR, range) length of stay in
hospital days)
Admission category:
1857 (60.8)507 (56.7)340 (61.9)1010 (62.6)Surgery
780 (25.5)297 (33.2)123 (22.4)360 (22.3)Medical
128 (4.2)30 (3.4)18 (3.3)80 (5.0)Trauma
291 (9.5)60 (6.7)68 (12.4)163 (10.1)Neurology/neurosurgery
ICU=intensive care unit; IQR=interquartile range; NA=not applicable.
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Table 3| Variables of PRE-DELIRIC model and regression coefficients
Shrunken regression coefficient*Odds ratio (95% CI)Regression coefficientVariable
0.041.04 (1.03 to 1.06)0.04Age (years)
0.061.06 (1.03 to 2.0)0.06APACHE-II score (per point)
Coma:
0.551.8 (1.1 to 3.1)0.59Drug induced
2.7018.5 (4.6 to 73.8)2.92Miscellaneous
2.8421.3 (5.9 to 77.1)3.06Combination
Admission category:
ReferenceReferenceReferenceSurgery
0.311.4 (0.9 to 2.2)0.33Medical
1.133.4 (1.7 to 6.8)1.22Trauma
1.384.5 (2.6 to 7.5)1.49Neurology/neurosurgery
1.053.1 (2.0 to 4.8)1.14Infection (yes)
0.291.4 (1.0 to 2.0)0.32Metabolic acidosis (yes)
Morphine use:
0.411.6 (0.8 to 3.1)0.440.01-7.1 mg/day
0.131.2 (0.8 to 1.8)0.147.2-18.6 mg/day
0.511.8 (1.1 to 2.7)0.55>18.6 mg/day
1.394.5 (2.8 to 7.4)1.51Sedation (yes)
0.031.03 (1.0 to 1.1)0.03Urea (mmol/L)
0.401.5 (1.1 to 2.3)0.43Urgent admission (%)
−6.31−6.76Intercept
APACHE=acute physiology and chronic health evaluation.
*Result of bootstrapping technique used to correct for overoptimistic estimation of model.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;344:e420 doi: 10.1136/bmj.e420 (Published 9 February 2012) Page 9 of 11
RESEARCH
Figures
Fig 1 Flow chart of development and temporal validation study
Fig 2 Area under receiver operating characteristics curve (AUROC) of pooled data for development (AUROC=0.86), temporal
validation (AUROC=0.89), and external validation (AUROC=0.84), resulting in AUROC of 0.85. AUROC was 0.59 (95% CI
0.49 to 0.70) for prediction by nurses and 0.59 (0.49 to 0.70) for prediction by physicians
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Fig 3 Calibration plot of pooled data, with calibration slope of 0.93 and intercept of −0.29
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